Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trials on NONS Spray for COVID-19 in Lancet Journal
Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high impact journal...
14 July, 2022
Read more